New potent anti APOB antisense compounds

Details for Australian Patent Application No. 2010258570 (hide)

Owner Santaris Pharma A/S

Inventors Nielsen, Niels Fisker; Straarup, Ellen Marie; Lindholm, Marie

Agent FB Rice

Pub. Number AU-A-2010258570

PCT Pub. Number WO2010/142805

Priority 61/253,090 20.10.09 US; PCT/ EP2009/067561 18.12.09 EP; 61/186,388 12.06.09 US

Filing date 14 June 2010

Wipo publication date 16 December 2010

International Classifications

A61K 31/712 (2006.01) - Nucleic acids or oligonucleotides having modified sugars, i.e. other than ribose or 2'-deoxyribose

A61K 31/713 (2006.01) - Double-stranded nucleic acids or oligonucleotides

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

C12N 15/113 (2010.01) Mutation or genetic engineering - Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides

Event Publications

15 December 2011 PCT application entered the National Phase

  PCT publication WO2010/142805 Priority application(s): WO2010/142805

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010258572-High elongation fibres

2010258566-Indole amide derivatives and related compounds for use in the treatment of neurodegenerative diseases